Skip to main content
ABVC BIOPHARMA, INC. logo

ABVC BIOPHARMA, INC. — Investor Relations & Filings

Ticker · ABVC ISIN · US00091F1066 US Manufacturing
Open in API
Filings indexed 780 across all filing types
Latest filing 2010-10-18 Capital/Financing Update
Country US United States of America
Listing US ABVC

About ABVC BIOPHARMA, INC.

https://abvcpharma.com/

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes drugs and medical devices to address unmet medical needs. The company focuses on advancing a pipeline of botanical, plant-based pharmaceuticals and medical technologies sourced from research institutions. Its therapeutic areas of focus include oncology, ophthalmology, and central nervous system disorders such as major depressive disorder (MDD) and adult attention-deficit/hyperactivity disorder (ADHD). Key products in development include Vitargus®, a biodegradable vitreous substitute for eye surgery, and botanical drug candidates for MDD and ADHD. Additionally, its subsidiary, BioKey, Inc., offers contract development and manufacturing services for nutritional and pharmaceutical products.

Recent filings

Filing Released Lang Actions
SALPIETRA NOTE EXTENSION
Capital/Financing Update Classification · 95% confidence The document is a letter dated October 15, 2010, from the CEO of Ecology Coatings to an individual regarding the extension of a promissory note maturity date and the issuance of an option to purchase shares. It discusses difficulties in raising new investment and proposes extending the note maturity by 30 days. The content is related to financing activities and capital structure changes, specifically about debt extension and share options. The document is short (1357 characters) and is not a formal report or financial statement. It is not an announcement of a report publication but a direct communication about financing terms. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2010-10-18 English
FORM 3
Director's Dealing
2010-10-07 English
FORM 3
Director's Dealing
2010-09-22 English
ELECTION OF NEW BOARD MEMBERS
Board/Management Information Classification · 100% confidence The document is a Form 8-K current report filed with the SEC, dated September 14, 2010. The key content is the election of new board members and information about their backgrounds. The document specifically mentions the election of James Orchard, Sally Judith Wiene Ramsey, and Daniel Rempinski to the Board of Directors. This fits the description of announcements related to changes in the company's board of directors or senior management. There is no financial data, earnings information, or other report content. The document is not a full annual or quarterly report, nor is it an earnings release or proxy statement. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is 3583 characters, which is consistent with a brief announcement rather than a full report.
2010-09-14 English
HEADQUARTERS LEASE WITH OMEGA
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filing with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement, specifically a lease agreement with Omega Development Corporation. There are no financial statements or comprehensive financial data presented, nor is this an earnings release or annual/interim report. The document is not a report publication announcement but the actual filing of a material event. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit into more specific categories like capital updates or management changes.
2010-09-02 English
3RD QUARTER 10-Q FY 2010
Interim / Quarterly Report Q3 2010
2010-08-16 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.